General Information
Shire MDD 209
A Phase 2, Multicenter, Double-blind, Parallel-group, Randomized, Placebo-controlled, Forced-dose Titration, Dose-ranging Efficacy and Safety Study of SPD489 in Combination with an Antidepressant in the Treatment of Adults with Major Depressive Disorder with Inadequate Response to Prospective Treatment with an Antidepressant.
| Protocol | |
|---|---|
| Identifier | SPD489-209 |
| UID | e4cec77f-83ae-4c9e-87a4-a88395bd442e |
| Status | Done - Archived |
| Phase | 2 |
| Category | Major Depressive Disorder / Adult |
| Launch Year | 2012 |
| NCT Number | - |
| Created | 2012-06-18 19:48 |
| Last Updated | 2012-06-18 19:48 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | 2013-04-03 | No |
| Enrollment Open | 2013-01-08 | No |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2012-11-29 | No |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2013-09-26 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Mohaupt, Stephen | SMohaupt | No |
| Recruiter | - | No | |
| Coordinator | Barnett, Omar | OBarnett | No |
| Regulatory | Aguirre, Sandra | SAguirre | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Shire Development, Inc. |
|---|---|
| Division | Shire Development, Inc. |
| Team | Shire Development, Inc. |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | IRBD ID No. 26414/54 |
|---|---|
| CRO | ICON Clinical Research, LLC |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
